Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28363102 | 0.98 | IDO1 (0.59) | IDO1LMNAKDM4EALDH1A1NPSR1 | |
| SCHEMBL15201533 | 0.98 | IDO1 (0.59) | IDO1LMNAKDM4EALDH1A1NPSR1 | |
| Ammonia Solution, Strong SCHEMBL4702116 | 0.98 | IDO1 (0.59) | IDO1LMNAKDM4EALDH1A1NPSR1 | |
| Hydrochloric Acid SCHEMBL7871281 | 0.96 | IDO1 (0.57) | IDO1LMNAKDM4EALDH1A1NPSR1 | |
| SCHEMBL2096243 | 0.93 | L3MBTL1 (0.54) | IDO1LMNAKDM4EL3MBTL1SIGMAR1 | |
| SCHEMBL8499737 | 0.91 | L3MBTL1 (0.57) | IDO1LMNAKDM4EL3MBTL1SIGMAR1 | |
| SCHEMBL8500355 | 0.91 | L3MBTL1 (0.57) | IDO1LMNAKDM4EL3MBTL1SIGMAR1 | |
| SCHEMBL8496079 | 0.91 | L3MBTL1 (0.57) | IDO1LMNAKDM4EL3MBTL1SIGMAR1 | |
| SCHEMBL12982429 | 0.91 | L3MBTL1 (0.57) | IDO1LMNAKDM4EL3MBTL1SIGMAR1 | |
| SCHEMBL8498124 | 0.91 | L3MBTL1 (0.57) | IDO1LMNAKDM4EL3MBTL1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4251591-A1 | FERTILISING AND/OR SOIL CONDITIONING COMPOSITION INTENDED FOR CULTURE SUBSTRATES AND/OR CULTURE SOLUTIONS | Agro Innovation International (FR) | 2023-10-04 | — | — | EP | claimed |
| WO-2022112695-A1 | FERTILISING AND/OR SOIL CONDITIONING COMPOSITION INTENDED FOR CULTURE SUBSTRATES AND/OR CULTURE SOLUTIONS | AGRO INNOVATION INTERNATIONAL (FR) | 2022-06-02 | — | — | WO | claimed |
| WO-2020018087-A1 | POLYURETHANE FOAM ADDITIVES TO IMPROVE FOAM ADHESION TO ORGANIC POLYMERS | EVONIK DEGUSSA GMBH (DE) | 2020-01-23 | — | — | WO | claimed |
| CN-104133289-B | A kind of manufacture method of electric moistening display part sept | 深圳市国华光电研究院 | 2017-03-29 | — | — | CN | claimed |
| CN-106380132-A | Application of surface tension adjustment reduction type polycarboxylate superplasticizer in preparing high-performance concrete | 广东红墙新材料股份有限公司 | 2017-02-08 | — | — | CN | claimed |
| CN-105295514-A | Paint remover | GUAN YONGHE | 2016-02-03 | — | — | CN | claimed |
| CN-104327638-A | Antimicrobial latex paint | QINGDAO TUOLIAN INFORMATION TECHNOLOGY CO LTD | 2015-02-04 | — | — | CN | claimed |
| CN-102414168-B | Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists | ACTELION PHARMACEUTICALS LTD | 2014-05-21 | — | — | CN | claimed |
| CN-102850839-B | Paint remover | SUZHOU DELER BUILDING MAT TECH | 2014-05-07 | — | — | CN | claimed |
| US-8563714-B2 | Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists | ACTELION PHARMACEUTICALS LTD. (CH) | 2013-10-22 | — | — | US | claimed |
| WO-2009020987-A2 | PROCESS FOR PREPARATION OF SWELLABLE AND DEGRADABLE MICROSPHERES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-02-12 | — | — | WO | claimed |
| US-20090041850-A1 | Process for preparation of swellable and degradable microspheres | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-02-12 | — | — | US | claimed |
| EP-2004702-A2 | PROCESS FOR PREPARATION OF SWELLABLE AND DEFORMABLE MICROSPHERES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-12-24 | — | — | EP | claimed |
| WO-2007120705-A2 | PROCESS FOR PREPARATION OF SWELLABLE AND DEFORMABLE MICROSPHERES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-10-25 | — | — | WO | claimed |
| US-20070237741-A1 | Medical treatment applications of swellable and deformable microspheres | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-10-11 | — | — | US | claimed |
| US-20070237742-A1 | Process for embolization using swellable and deformable microspheres | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-10-11 | — | — | US | claimed |
| US-20070237956-A1 | Process for preparation of swellable and deformable microspheres | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-10-11 | — | — | US | claimed |
| CN-1211359-C | Novel phenylalkoxy-phenyl derivatives | ASTRAZENECA AB (SE) | 2005-07-20 | — | — | CN | claimed |
| CN-1635181-A | Airplane cleaning agent | CHANGSHA AISEN EQUIPMENT MAINT (CN) | 2005-07-06 | — | — | CN | claimed |
| US-20050054651-A1 | Compositions and methods for the treatment of disease associated with Trp-p8 expression | DENDREON CORPORATION (US) | 2005-03-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054651-A1 | Compositions and methods for the treatment of disease associated with Trp-p8 expression | TRPC4, TRPC3, TRPC1 | IDO1 1959/4885LMNA 1738/4885KDM4E 4239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.